Annual Total Long Term Liabilities
$2.81 B
+$40.36 M+1.46%
December 31, 2023
Summary
- As of February 7, 2025, EXAS annual total long term liabilities is $2.81 billion, with the most recent change of +$40.36 million (+1.46%) on December 31, 2023.
- During the last 3 years, EXAS annual total long term liabilities has risen by +$754.88 million (+36.71%).
- EXAS annual total long term liabilities is now at all-time high.
Performance
EXAS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.81 B
+$2.11 M+0.07%
September 30, 2024
Summary
- As of February 7, 2025, EXAS quarterly total long term liabilities is $2.81 billion, with the most recent change of +$2.11 million (+0.07%) on September 30, 2024.
- Over the past year, EXAS quarterly long term liabilities has increased by +$255.80 million (+10.00%).
- EXAS quarterly long term liabilities is now -2.25% below its all-time high of $2.88 billion, reached on March 31, 2023.
Performance
EXAS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EXAS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | +10.0% |
| 3 y3 years | +36.7% | +13.2% |
| 5 y5 years | +297.7% | +430.7% |
EXAS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1.5% | -2.3% | +10.0% |
| 5 y | 5-year | at high | +186.5% | -2.3% | +186.8% |
| alltime | all time | at high | -100.0% | -2.3% | >+9999.0% |
Exact Sciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.81 B(+0.1%) |
| Jun 2024 | - | $2.81 B(+9.9%) |
| Mar 2024 | - | $2.56 B(-9.0%) |
| Dec 2023 | $2.81 B(+1.5%) | $2.81 B(-0.4%) |
| Sep 2023 | - | $2.82 B(+0.4%) |
| Jun 2023 | - | $2.81 B(-2.4%) |
| Mar 2023 | - | $2.88 B(+3.9%) |
| Dec 2022 | $2.77 B(-0.3%) | $2.77 B(-0.1%) |
| Sep 2022 | - | $2.77 B(-0.4%) |
| Jun 2022 | - | $2.78 B(+1.2%) |
| Mar 2022 | - | $2.75 B(-1.0%) |
| Dec 2021 | $2.78 B(+35.2%) | $2.78 B(+11.8%) |
| Sep 2021 | - | $2.49 B(-0.1%) |
| Jun 2021 | - | $2.49 B(+1.3%) |
| Mar 2021 | - | $2.46 B(+19.5%) |
| Dec 2020 | $2.06 B(+109.6%) | $2.06 B(+16.5%) |
| Sep 2020 | - | $1.76 B(+1.7%) |
| Jun 2020 | - | $1.73 B(+3.2%) |
| Mar 2020 | - | $1.68 B(+71.2%) |
| Dec 2019 | $981.21 M(+38.8%) | $981.21 M(+85.0%) |
| Sep 2019 | - | $530.29 M(+1.2%) |
| Jun 2019 | - | $523.95 M(-36.6%) |
| Mar 2019 | - | $825.95 M(+16.8%) |
| Dec 2018 | $706.91 M(+6956.4%) | $706.91 M(+3.0%) |
| Sep 2018 | - | $686.11 M(+4.7%) |
| Jun 2018 | - | $655.30 M(+32.0%) |
| Mar 2018 | - | $496.57 M(+4856.8%) |
| Dec 2017 | $10.02 M(-9.4%) | $10.02 M(-3.2%) |
| Sep 2017 | - | $10.35 M(-2.5%) |
| Jun 2017 | - | $10.61 M(-1.8%) |
| Mar 2017 | - | $10.80 M(-2.3%) |
| Dec 2016 | $11.05 M(+5.8%) | $11.05 M(+2.1%) |
| Sep 2016 | - | $10.82 M(+0.7%) |
| Jun 2016 | - | $10.75 M(-0.3%) |
| Mar 2016 | - | $10.78 M(+3.1%) |
| Dec 2015 | $10.45 M(+65.4%) | $10.45 M(+13.7%) |
| Sep 2015 | - | $9.19 M(-2.7%) |
| Jun 2015 | - | $9.45 M(+54.1%) |
| Mar 2015 | - | $6.13 M(-3.0%) |
| Dec 2014 | $6.32 M(+77.5%) | $6.32 M(+124.9%) |
| Sep 2014 | - | $2.81 M(-9.8%) |
| Jun 2014 | - | $3.12 M(-6.6%) |
| Mar 2014 | - | $3.34 M(-6.2%) |
| Dec 2013 | $3.56 M | $3.56 M(+86.9%) |
| Sep 2013 | - | $1.90 M(+18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.61 M(-4.8%) |
| Mar 2013 | - | $1.69 M(-18.2%) |
| Dec 2012 | $2.07 M(-62.3%) | $2.07 M(-35.0%) |
| Sep 2012 | - | $3.18 M(-6.9%) |
| Jun 2012 | - | $3.42 M(-23.2%) |
| Mar 2012 | - | $4.45 M(-18.8%) |
| Dec 2011 | $5.48 M(-42.9%) | $5.48 M(-15.8%) |
| Sep 2011 | - | $6.51 M(-13.7%) |
| Jun 2011 | - | $7.54 M(-12.0%) |
| Mar 2011 | - | $8.57 M(-10.7%) |
| Dec 2010 | $9.60 M(-27.0%) | $9.60 M(-9.7%) |
| Sep 2010 | - | $10.63 M(-3.1%) |
| Jun 2010 | - | $10.97 M(-8.1%) |
| Mar 2010 | - | $11.94 M(-9.2%) |
| Dec 2009 | $13.15 M(+298.5%) | $13.15 M(-1.7%) |
| Sep 2009 | - | $13.37 M(-8.5%) |
| Jun 2009 | - | $14.62 M(-7.9%) |
| Mar 2009 | - | $15.87 M(+380.8%) |
| Dec 2008 | $3.30 M(+22.2%) | $3.30 M(+95.5%) |
| Sep 2008 | - | $1.69 M(-16.6%) |
| Jun 2008 | - | $2.02 M(-14.3%) |
| Mar 2008 | - | $2.36 M(-12.5%) |
| Dec 2007 | $2.70 M(+6.1%) | $2.70 M(-17.9%) |
| Sep 2007 | - | $3.29 M(-2.6%) |
| Jun 2007 | - | $3.38 M(+132.2%) |
| Mar 2007 | - | $1.45 M(-42.9%) |
| Dec 2006 | $2.54 M(-63.2%) | $2.54 M(-30.0%) |
| Sep 2006 | - | $3.64 M(-23.1%) |
| Jun 2006 | - | $4.73 M(-18.8%) |
| Mar 2006 | - | $5.82 M(-15.8%) |
| Dec 2005 | $6.91 M(-38.7%) | $6.91 M(-13.6%) |
| Sep 2005 | - | $8.00 M(-12.0%) |
| Jun 2005 | - | $9.09 M(-10.7%) |
| Mar 2005 | - | $10.18 M(-9.7%) |
| Dec 2004 | $11.27 M(-28.3%) | $11.27 M(-8.7%) |
| Sep 2004 | - | $12.34 M(-8.4%) |
| Jun 2004 | - | $13.47 M(-7.7%) |
| Mar 2004 | - | $14.60 M(-7.2%) |
| Dec 2003 | $15.73 M(+142.2%) | $15.73 M(-6.3%) |
| Sep 2003 | - | $16.78 M(+195.2%) |
| Jun 2003 | - | $5.68 M(-6.7%) |
| Mar 2003 | - | $6.09 M(-6.2%) |
| Dec 2002 | $6.49 M(>+9900.0%) | $6.49 M(-5.9%) |
| Sep 2002 | - | $6.90 M(-5.5%) |
| Jun 2002 | - | $7.30 M |
| Dec 1999 | $0.00 | - |
FAQ
- What is Exact Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Exact Sciences?
- What is Exact Sciences annual total long term liabilities year-on-year change?
- What is Exact Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Exact Sciences?
- What is Exact Sciences quarterly long term liabilities year-on-year change?
What is Exact Sciences annual total long term liabilities?
The current annual total long term liabilities of EXAS is $2.81 B
What is the all time high annual total long term liabilities for Exact Sciences?
Exact Sciences all-time high annual total long term liabilities is $2.81 B
What is Exact Sciences annual total long term liabilities year-on-year change?
Over the past year, EXAS annual total long term liabilities has changed by +$40.36 M (+1.46%)
What is Exact Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of EXAS is $2.81 B
What is the all time high quarterly long term liabilities for Exact Sciences?
Exact Sciences all-time high quarterly total long term liabilities is $2.88 B
What is Exact Sciences quarterly long term liabilities year-on-year change?
Over the past year, EXAS quarterly total long term liabilities has changed by +$255.80 M (+10.00%)